Evidence map›Paper›PMID 38157260›Full record

ArticleAging2023

Clinical value of SLC12A9 for diagnosis and prognosis in colorectal cancer.

Wang Du, Guozhi Xia, Liang Chen, Lingjun Geng, Rubin Xu, Qingqing Han, Xiaomei Ying, Hongzhu Yu

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wang DuDepartment of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, China.
Guozhi XiaDepartment of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, China.
Liang ChenDepartment of Hepatobiliary and Pancreatic Surgery, Conversion therapy center for Hepatobiliary and Pancreatic Tumors, First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314041, China.
Lingjun GengDepartment of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, China.
Rubin XuDepartment of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, China.
Qingqing HanDepartment of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, China.
Xiaomei YingSuzhou Hospital of Anhui Medical University, Suzhou, Anhui 234000, China.
Hongzhu YuDepartment of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, China.
Fuyang Second People's Hospital · CNAnhui Medical University · CNFirst Hospital of Jiaxing · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe goal of the study is to assess the clinical value and the potential mechanism of

methodsIn this study, the expression level and the receiver operating characteristic curve analysis of

resultsWe found that

conclusionIn conclusion, our study comprehensively analyzed the clinical value of SLC12A9 and its potential mechanism, as well as immune cell infiltration, which may accelerate the diagnosis and improve the prognosis of CRC.

Indexed as

Colorectal NeoplasmsNomogramsSodium-Potassium-Chloride SymportersHumansPrognosisROC CurveSurvival AnalysisSLC12A9 protein, humanSodium-Potassium-Chloride Symporterscolorectal cancerdiagnosisprognosissingle cellSLC12A9

Identifiers

PMID38157260
PMCPMC10781446
OpenAlexW4390319907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.